Literature DB >> 16637425

[Cohort study on incidence of ARDS in patients admitted to the ICU and prognostic factors of mortality].

O Roca1, J Sacanell, C Laborda, M Pérez, J Sabater, M J Burgueño, L Domínguez, J R Masclans.   

Abstract

OBJECTIVE: Analyze acute respiratory distress syndrome (ARDS) in patients admitted to an Intensive Care Medicine Service (ICMS) and prognostic factors of mortality in these patients.
DESIGN: Prospective study of all the patients admitted consecutively in the ICMS from January 1998 to February 2003. SCOPE: ICMS of a third level university site with 32 beds in its General Area and 10 beds in the Traumatology Area. PATIENTS: Patients who met the ARDS criteria of the European-North American Consensus Conference at any time during admission in ICMS. ENDPOINTS OF INTEREST: Mortality at 28 days.
RESULTS: One hundred and ninety-one patients (3.4 of all the admissions in ICMS) had ARDS criteria. The origin of ARDS was intrapulmonary in 63%. A total of 77% of the patients had multiorgan dysfunction and 26% respiratory superinfection. Median stay in the ICMS was 20 days. Mortality at 28 days was 48% and hospital mortality 58%. Multivariant analysis showed that the variables associated independently with an increase in mortality were the following: APACHE II > 22 (odds ratio [OR] 2.7; 95% CI: 1.3-5.8; p = 0.007), minimum PaO2/FIO2 during evolution of ARDS < 81 mmHg (odds ratio 5.5; 95% CI: 2.6-11.9; p < 0.0001), dysfunction > or = 3 organs (odds ratio 11.8; 95% CI: 2.5-55.4; p = 0.002).
CONCLUSIONS: ARDS is an entity with elevated mortality whose prognosis is associated not only with the seriousness of pulmonary function deterioration but also of systemic function, on which some treatment could modulate its evolution.

Entities:  

Mesh:

Year:  2006        PMID: 16637425     DOI: 10.1016/s0210-5691(06)74455-2

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  7 in total

1.  Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature.

Authors:  G Umberto Meduri; Paul E Marik; George P Chrousos; Stephen M Pastores; Wiebke Arlt; Albertus Beishuizen; Faran Bokhari; Gary Zaloga; Djillali Annane
Journal:  Intensive Care Med       Date:  2007-11-14       Impact factor: 17.440

2.  Using sonography to assess lung recruitment in patients with acute respiratory distress syndrome.

Authors:  Greta Gardelli; Francesco Feletti; Emiliano Gamberini; Stefano Bonarelli; Andrea Nanni; Maurizio Mughetti
Journal:  Emerg Radiol       Date:  2008-10-01

3.  Effects of an omega-3 fatty acid-enriched lipid emulsion on eicosanoid synthesis in acute respiratory distress syndrome (ARDS): A prospective, randomized, double-blind, parallel group study.

Authors:  Joan Sabater; Joan Ramon Masclans; Judit Sacanell; Pilar Chacon; Pilar Sabin; Mercè Planas
Journal:  Nutr Metab (Lond)       Date:  2011-04-08       Impact factor: 4.169

4.  High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study.

Authors:  Norihito Omote; Naoyuki Matsuda; Naozumi Hashimoto; Kazuki Nishida; Koji Sakamoto; Akira Ando; Yoshio Nakahara; Mitsuaki Nishikimi; Michiko Higashi; Shigeyuki Matsui; Yoshinori Hasegawa
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

5.  Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study.

Authors:  Niall D Ferguson; Fernando Frutos-Vivar; Andrés Esteban; Federico Gordo; Teresa Honrubia; Oscar Peñuelas; Alejandro Algora; Gema García; Alejandra Bustos; Inmaculada Rodríguez
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 6.  The Role of Omega-3 Polyunsaturated Fatty Acids in the Treatment of Patients with Acute Respiratory Distress Syndrome: A Clinical Review.

Authors:  M García de Acilu; S Leal; B Caralt; O Roca; J Sabater; J R Masclans
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

7.  Psychometric properties of Patient Reported Outcome Measures (PROMs) in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS).

Authors:  Hiral Anil Shah; Melina Dritsaki; Joshua Pink; Stavros Petrou
Journal:  Health Qual Life Outcomes       Date:  2016-01-27       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.